Search Within

Andrew D Seidman

  1. "2004"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (1)
Groups
  1. Breast Medicine Service (8)
  2. Department of Medicine (8)
  3. Solid Tumor Oncology Division (8)
  4. Survivorship Research (4)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  6. Biostatistics Service (2)

More Groups

People
  1. Clifford Hudis (4)
  2. Larry Norton (3)
  3. Chau Dang (2)
  4. Gabriella D'Andrea-Carlino (2)
  5. Katherine Panageas (2)
  6. Maria Theodoulou-Haber (2)

More People

Years
  1. 2004 (8)
Publications
  1. Clinical Breast Cancer (2)
  2. Clinical Cancer Research (2)
  3. Oncology (Norwalk) (2)
  4. Journal of Clinical Oncology (1)
  5. Journal of the National Comprehensive Cancer Network (1)
Publishers
  1. American Association for Cancer Research (2)
  2. C M P Medica LLC * The Oncology Group (2)
  3. Elsevier Inc. (2)
  4. American Society of Clinical Oncology (1)
  5. Harborside Press (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CALGB 9840: Phase III study of weekly (W) paclitaxel (P) via 1-hour(h) infusion versus standard (S) 3h infusion every third week in the treatment of metastatic breast cancer (MBC), with trastuzumab (T) for HER2 positive MBC and randomized for T in HER2 normal MBC
    Meeting Abstract

    Seidman, A. D.; Berry, D.; Cirrincione, C.; Harris, L.; Dressler, L.; Muss, H.; Norton, L.; Winer, E.; Hudis, C.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • The Emens/Davidson article reviewed [Trastuzumab in breast cancer]
    Journal Article

    Danso, M. A.; Seidman, A. D.
    Oncology (Norwalk) (2004)

    Fulltext@MSK | Save
  • Gemcitabine and docetaxel in metastatic breast cancer
    Journal Article

    Seidman, A. D.
    Oncology (Norwalk) (2004)

    Fulltext@MSK | Save
  • Single-agent gemcitabine in the treatment of advanced breast cancer
    Journal Article

    Modi, S.; Seidman, A. D.
    Clinical Breast Cancer (2004)

    Fulltext@MSK | Save
  • Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatments
    Journal Article

    Dang, C. T.; Dannenberg, A. J.; Subbaramaiah, K.; Dickler, M. N.; Moasser, M. M.; Seidman, A. D.; D'Andrea, G. M.; Theodoulou, M.; Panageas, K. S.; Norton, L.; more...
    Clinical Cancer Research (2004)

    Fulltext@MSK | Save
  • Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancer
    Journal Article

    Dang, C. T.; D'Andrea, G. M.; Moynahan, M. E.; Dickler, M. N.; Seidman, A. D.; Fornier, M.; Robson, M. E.; Theodoulou, M.; Lake, D.; Currie, V. E.; more...
    Clinical Cancer Research (2004)

    Fulltext@MSK | Save
  • Effect of cardiac dysfunction of treatment outcomes in women receiving trastuzumab for HER2-overexpressing metastatic breast cancer
    Journal Article

    Tripathy, D.; Seidman, A.; Keefe, D.; Hudis, C.; Paton, V.; Lieberman, G.
    Clinical Breast Cancer (2004)

    Fulltext@MSK | Save
  • New advances in taxane therapy: The next generation
    Journal Article

    Seidman, A. D.
    Journal of the National Comprehensive Cancer Network (2004)

    Fulltext@MSK | Save